| 参考文献 |
［1］ Dianzani C,Conforti C,Giuffrida R,et al.Current therapies for actinickeratosis[J].International journal of dermatology,2020,59(6):677-684.
［2］ O’shaughnessy R F L.Understanding actinic keratosis to reduce squa-mous cell carcinoma incidence[J].The British journal of dermatology,2020,182(4):834-835.
［3］ Combalia A,Carrera C.Squamous Cell Carcinoma:An Update on Di-agnosis and Treatment[J].Dermatology practical&conceptual,2020,10(3):e2020066.
［4］ Corchado-cobos R,García-sancha N,González-sarmiento R,et al.Cu-taneous Squamous Cell Carcinoma:From Biology to Therapy[J].Inter-national journal of molecular sciences,2020,21(8):2956.
［5］ Guorgis G,Anderson C D,Lyth J,et al.Actinic Keratosis Diagnosis andIncreased Risk of Developing Skin Cancer:A 10-year Cohort Study of17,651 Patients in Sweden[J].Acta Derm Venereol,2020,100(8):128.
［6］ Kim Y,SU K A,Asgari M M.Correlates of multiple cutaneous squa-mous cell carcinoma:A retrospective cohort study[J].Journal of theAmerican Academy of Dermatology,2020,82(2):497-499.
［7］ Stratigos A,Garbe C,Lebbe C,et al.Diagnosis and treatment of inva-sive squamous cell carcinoma of the skin:European consensus-basedinterdisciplinary guideline[J].European journal of cancer (Oxford,En-gland:1990),2015,51(14):1989-2007.
［8］ Moran J M,Phelps P O.Periocular skin cancer:Diagnosis and manage-ment[J].Disease-a-month:DM,2020,66(10):101046.
|
典型日光性角化病发展为转移性鳞状细胞癌 1 例.pdf (1244KB)